Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization

Journal of Infectious Diseases

Volumn 210, Issue 6, 2014, Pages 982-991

  Wang, Nai Yu ^a   Patras, Kathryn A ^a   Seo, Ho Seong ^b,c   Cavaco, Courtney K ^a   Rösler, Berenice ^a   Neely, Melody N ^d   Sullam, Paul M ^b   Doran, Kelly S ^a,e  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Korea Atomic Energy Research Institute   (South Korea)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Fibrinogen; GBS; Srr1; Vaginal colonization

Indexed keywords

FIBRINOGEN; SERINE PROTEINASE; SERINE RICH REPEAT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STREPTOCOCCUS AGALACTIAE; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM; VAGINAL COLONIZATION;

FIBRINOGEN; GBS; SRR1; VAGINAL COLONIZATION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIUM; FEMALE; FIBRINOGEN; MEMBRANE GLYCOPROTEINS; MICE; SERINE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; VAGINAL DISEASES;

EID: 84907349736     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu151     Document Type: Conference Paper

References (47)

1. Dillon HC Jr, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982; 145:794-9.
2. Meyn LA, Krohn MA, Hillier SL. Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. Am J Obstet Gynecol 2009; 201:76 e1-7.
3. Desa DJ, Trevenen CL. Intrauterine infections with group B beta-haemolytic streptococci. Br J Obstet Gynaecol 1984; 91:237-9.
4. Maisey HC, Quach D, Hensler ME, et al. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J 2008; 22:1715-24.
5. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1-36.
6. Prevention CfDCa. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2008, 2009.
7. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 41:839-47.
8. Sheen TR, Jimenez A,Wang NY, Banerjee A, van Sorge NM, Doran KS. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol 2011; 193:6834-42.
9. Stinson MW, Alder S, Kumar S. Invasion and killing of human endothelial cells by viridans group streptococci. Infect Immun 2003; 71:2365-72.
10. Siboo IR, Chambers HF, Sullam PM. Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 2005; 73:2273-80.
11. Samen U, Eikmanns BJ, Reinscheid DJ, Borges F. The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect Immun 2007; 75:5405-14.
12. Pyburn TM, Bensing BA, Xiong YQ, et al. A structural model for binding of the serine-rich repeat adhesin GspB to host carbohydrate receptors. PLoS Pathog 2011; 7:e1002112.
13. Seifert KN, Adderson EE, Whiting AA, Bohnsack JF, Crowley PJ, Brady LJ. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 2006; 152:1029-40.
14. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis 2009; 199: 1479-87.
15. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-65.
16. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog 2012; 8:e1002947.
17. Seo HS, Misanov G, Seepersaud R, et al. Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae. J Biol Chem 2013; 288:35982-96.
18. Ponnuraj K, Bowden MG, Davis S, et al. A "dock, lock, and latch" structural model for a staphylococcal adhesin binding to fibrinogen. Cell 2003; 115:217-28.
19. Wilkinson HW. Nontypable group B streptococci isolated from human sources. J Clin Microbiol 1977; 6:183-4.
20. Wilson CB, Weaver WM. Comparative susceptibility of group B streptococci and Staphylococcus aureus to killing by oxygen metabolites. J Infect Dis 1985; 152:323-9.
21. Lancefield RC, McCarty M, Everly WN. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 1975; 142: 165-79.
22. Wessels MR, Paoletti LC, Rodewald AK, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993; 61:4760-6.
23. Madoff LC, Michel JL, Kasper DL. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun 1991; 59:204-10.
24. Doran KS, Engelson EJ, Khosravi A, et al. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 2005; 115:2499-507.
25. Pritzlaff CA, Chang JC, Kuo SP, Tamura GS, Rubens CE, Nizet V. Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mole Microbiol 2001; 39:236-47.
26. Fichorova RN, Rheinwald JG, Anderson DJ. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 1997; 57:847-55.
27. Patras KA, Wang NY, Fletcher EM, et al. Group B Streptococcus CovR regulation modulates host immune signaling pathways to promote vaginal colonization. Cell Microbiol 2013; 288:35982-96.
28. Poisson DM, Evrard ML, Freneaux C, Vives MI, Mesnard L. Evaluation of CHROMagar StrepB agar, an aerobic chromogenic medium for prepartum vaginal/rectal Group B Streptococcus screening. J Microbiol Methods 2011; 84:490-1.
29. Rivera J, Vannakambadi G, Hook M, Speziale P. Fibrinogen-binding proteins of Gram-positive bacteria. Thromb Haemost 2007; 98:503-11.
30. Dramsi S, Caliot E, Bonne I, et al. Assembly and role of pili in group B streptococci. Mole Microbiol 2006; 60:1401-13.
31. Pereira M, Rybarczyk BJ, Odrljin TM, Hocking DC, Sottile J, Simpson-Haidaris PJ. The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J Cell Sci 2002; 115:609-17.
32. Lee SY, Lee KP, Lim JW. Identification and biosynthesis of fibrinogen in human uterine cervix carcinoma cells. Thromb Haemost 1996; 75: 466-70.
33. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biolog Chem 1993; 268:14116-24.
34. Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89:873-82.
35. Tang LJ, De Seta F, Odreman F, et al. Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 2007; 6:2874-83.
36. Dasari S, Pereira L, Reddy AP, et al. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 2007; 6: 1258-68.
37. Whitney CG, Daly S, Limpongsanurak S, et al. The international infections in pregnancy study: group B streptococcal colonization in pregnant women. J Matern Fetal Neonatal Med 2004; 15:267-74.
38. Tsui MH, Ip M, Ng PC, Sahota DS, Leung TN, Lau TK. Change in prevalence of group B Streptococcus maternal colonisation in Hong Kong. Hong Kong Med J 2009; 15:414-9.
39. Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J 2011; 30:759-63.
40. van Belkum A. Short sequence repeats in microbial pathogenesis and evolution. Cell Mol Life Sci 1999; 56:729-34.
41. Simpson-Haidaris PJ, Courtney MA, Wright TW, Goss R, Harmsen A, Gigliotti F. Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia. Infect Immun 1998; 66:4431-9.
42. Lawrence SO, Simpson-Haidaris PJ. Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost 2004; 92:234-43.
43. Hemangi C. Chapter 1. In: Vinita S. Medical and Surgical Diagnostic Disorders in Pregnancy. 1st ed. London: JP Brothers Medical Publishers, 2003:5.
44. Schubert A, Zakikhany K, Schreiner M, et al. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mole Microbiol 2002; 46:557-69.
45. Schubert A, Zakikhany K, Pietrocola G, et al. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun 2004; 72:6197-205.
46. Gutekunst H, Eikmanns BJ, Reinscheid DJ. The novel fibrinogen-binding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect Immun 2004; 72:3495-504.
47. Papasergi S, Lanza Cariccio V, Pietrocola G, et al. Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. PloS One 2013; 8: e75266.